PBH Prestige Consumer Healthcare Inc

Prestige Brands Holdings, Inc. to Release Fiscal 2017 Second Quarter Earnings on November 3rd

Prestige Brands Holdings, Inc. (NYSE:PBH) today announced that it will issue its fiscal 2017 second quarter earnings release on Thursday, November 3, 2016 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.

To access the call, listeners calling from within North America may dial 844-233-9440 about 15 minutes prior to the start of the call. Those wishing to access the call from outside North America should dial 574-990-1016. The conference ID is 94506453. The Company will provide a live Internet webcast as well as an archived replay, which can be accessed from the Investor Relations page of http://prestigebrands.com.

Telephonic replays will be available for two weeks following completion of the live call and can be accessed at 855-859-2056 within North America, and at 404-537-3406 from outside North America. The conference ID is 94506453.

About Prestige Brands Holdings, Inc.

Prestige Brands markets and distributes brand name over-the-counter healthcare and household cleaning products throughout the U.S. and Canada, Australia, and in certain other international markets. Core brands include Monistat® women’s health products, Nix® lice treatments, Chloraseptic® sore throat treatments, Compound W® wart treatments, Clear Eyes® eye care products, DenTek® oral care products, Little Remedies® pediatric products, The Doctor’s® NightGuard® dental protector, Efferdent® denture care products, Luden’s® throat drops, Dramamine® motion sickness treatments, BC® and Goody’s® headache remedies, Beano® gas prevention, Debrox® earwax remover, and in Canada, Gaviscon® antacid.

EN
05/10/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Prestige Consumer Healthcare Inc

 PRESS RELEASE

Prestige Consumer Healthcare Inc. Reports Second Quarter and First Hal...

Prestige Consumer Healthcare Inc. Reports Second Quarter and First Half Fiscal 2026 Results Revenue of $274.1 million in Q2, ahead of outlookDiluted EPS of $0.86 in Q2 and Adjusted Diluted EPS of $1.07, versus prior year Q2 Diluted EPS of $1.09Repurchased approximately 1.1 million shares opportunistically in Q2Fiscal 2026 revenue outlook unchanged; Adjusted Diluted EPS outlook updated to $4.54 to $4.58, high end of previous range TARRYTOWN, N.Y., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its second quarter and firs...

 PRESS RELEASE

Prestige Consumer Healthcare to Release Fiscal 2026 Second Quarter Ear...

Prestige Consumer Healthcare to Release Fiscal 2026 Second Quarter Earnings Results TARRYTOWN, N.Y., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2026 second quarter and first half earnings release on Thursday, November 6, 2025 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET. To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of . To participate in the confere...

 PRESS RELEASE

Prestige Consumer Healthcare to Present at the Barclays Global Consume...

Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference TARRYTOWN, N.Y., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the Barclays Global Consumer Staples Conference on Thursday, September 4, 2025 at 12:45 p.m. ET. All interested parties may access a live webcast of this event at under the “Investors” section and the “Events and Presentations” tab, or by using the following link: For those unable to participate during the live webcast, a replay option will be available on the C...

 PRESS RELEASE

Prestige Consumer Healthcare Inc. Reports Fiscal 2026 First Quarter Re...

Prestige Consumer Healthcare Inc. Reports Fiscal 2026 First Quarter Results Revenue of $249.5 million in Q1; decline driven by limited eye care supplyDiluted EPS of $0.95 in Q1, up approximately 6% versus prior year Adjusted Diluted EPS of $0.90Announces agreement to acquire current eye care supplier Pillar5 PharmaRevising fiscal 2026 revenue outlook to $1,100 to $1,115 million and Diluted EPS outlook to $4.50 to $4.58 TARRYTOWN, N.Y., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its first quarter fiscal 2026 ended Ju...

 PRESS RELEASE

Prestige Consumer Healthcare to Release Fiscal 2026 First Quarter Earn...

Prestige Consumer Healthcare to Release Fiscal 2026 First Quarter Earnings Results TARRYTOWN, N.Y., July 15, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2026 first quarter earnings release on Thursday, August 7, 2025 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET. To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of . To participate in the conference call via ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch